TransUnion Q3 Beat Can't Mask Margin Pressure
TransUnion extended its EPS beat streak to four with Q3 results, but margin pressure and zero insider purchases against $2.36M in sales suggest market confidence may be misplaced. Recovery hinges on w
TransUnion Q3 Beat Can't Mask Margin Pressure
NEW YORK, October 29 —
TransUnion (TRU) extended a streak of consecutive EPS beats with Q3 2026 results and projected solid Q4 guidance. The same report drew headlines for margin pressure, and not one executive purchased a single share across 90 days of selling from $84.42 down to $62.29.
- Four consecutive EPS beats before Q3 2026; Q3 added another with solid Q4 guidance projected.
- Q3 results exposed margin pressure; TRU carries $5.46B in total debt against $0.88B in cash.
- Net insider open-market sales totaled approximately $2.36M over 90 days; zero open-market purchases.
What the Beat Streak Is Papering Over
TransUnion, which sells credit reports, identity verification, fraud management, and analytics to financial services, insurance, and technology clients across its U.S. Markets and International segments, has been growing fast: trailing twelve-month revenue is $5.04 billion, up 12.2% year over year, and Q2 2026 revenue of $1.31 billion grew 14.9% year over year. The Q3 report, filed as an 8-K on October 27, extended that streak but simultaneously surfaced margin pressure. Equifax reported 9.6% revenue growth in the same Q3 season, in line with consensus, without a comparable margin overhang. A business growing revenue at that pace while margins compress tends to see multiple contraction before recovery.
The Selling Pattern No Headline Mentioned
Starting in late August, every recorded insider transaction at TransUnion was a sale. Chief Technology Officer Venkat Achanta sold 23,287 shares at $77.00 on September 10 for proceeds of approximately $1.79 million. On September 1, both division presidents, Todd Skinner of International and Steven Chaouki of U.S. Markets, each sold 1,000 shares at $84.42. By October 1, Skinner sold again at $62.29, a 26% step-down from his own September price, and Mohamed Abdelsadek, EVP of Global Solutions, also sold at $62.29 against his prior price of $79.07. Net open-market sales across the period totaled approximately $2.36 million, per Form 4 filings.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| TRU | $14.2B | 13.8x | -7.0% |
| EFX | $20.8B | 18.6x | -16.8% |
| VRSK | $24.9B | 21.8x | -12.8% |
| SSNC | $18.9B | 10.4x | -3.8% |
| TNET | $2.9B | 13.0x | +15.0% |
| TYL | $15.3B | 24.3x | -24.5% |
What Q4 Needs to Deliver
At $74.39, TRU trades 17% below the $89.95 consensus price target, a gap that implies expected recovery the current insider behavior does not support. The bull case requires Q4 results to show margin stabilization alongside the guidance beat. The specific number to watch: whether Q4 margins recover or extend the compression from Q3. Against $5.46 billion in total debt, there is limited slack for a second sequential miss; Bank of America holds a Hold. The forward P/E calculator can stress-test what a multiple re-rate demands. Run the free TransUnion deep-dive → before Q4 numbers land.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did TransUnion beat Q3 earnings?
Yes, TransUnion reported its fourth consecutive EPS beat in Q3 2026 with solid Q4 guidance projected. However, the report exposed margin pressure that the positive earnings surprise may be masking.
Why are TransUnion executives selling stock?
From late August through October, executives sold approximately $2.36M in stock with zero open-market purchases. Chief Technology Officer Venkat Achanta, division presidents Todd Skinner and Steven Chaouki, and EVP Mohamed Abdelsadek all sold shares, with some timing purchases just before steep declines from $84.42 to $62.29.
What is TransUnion's margin issue?
Q3 results exposed margin compression at the same time Equifax reported 9.6% revenue growth in line with consensus without a comparable margin problem. A business growing revenue at TransUnion's pace while margins compress typically sees multiple contraction before recovery.
What is TransUnion's price target?
The consensus price target for TRU is $89.95, implying 17% upside from its current $74.39 level. However, the stock needs Q4 results showing margin stabilization for that recovery thesis to hold.
How much debt does TransUnion carry?
TransUnion carries $5.46B in total debt against $0.88B in cash. Bank of America rates the stock a Hold, and with that debt load, the company has limited room for a second sequential margin miss in Q4.
TransUnion filed its Q3 2026 earnings 8-K on October 27, extending a streak of consecutive EPS beats and guiding for a solid Q4 — yet the same report drew headlines for margin pressure, and not one executive purchased a single share during a 90-day stretch in which insider transaction prices fell from $84.42 to $62.29.
Sources & Filings